A study to assess the long-term safety of tazemetostat
This study will provide continuing availability to tazemetostat for people that have previously completed participation in a tazemetostat study, either with monotherapy (single drug treatment) or combination therapy. The aim of the study will be to assess the long-term safety of tezemetostat.
A study to assess the long-term safety of tazemetostat
- 11 December 2024 - 1 mins read
This study will provide continuing availability to tazemetostat for people that have previously completed participation in a tazemetostat study, either with monotherapy (single drug treatment) or combination therapy. The aim of the study will be to assess the long-term safety of tezemetostat.
Related Clinical Trials
11 December 2024
1 mins read
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
11 December 2024
1 mins read
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
11 December 2024
1 mins read
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
11 December 2024
1 mins read
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
11 December 2024
1 mins read
Dysport® Adult Lower Limb Spasticity Follow-on Study
11 December 2024
1 mins read
Dysport® Pediatric Lower Limb Spasticity Study
11 December 2024
1 mins read
Dysport® Adult Lower Limb Spasticity Study
11 December 2024
1 mins read
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
11 December 2024
1 mins read
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
11 December 2024
1 mins read